GLYC - GlycoMimetics Stock Trading

GlycoMimetics Inc.(NASDAQ: GLYC) stock trading, description, contact, officers and directors.

About GlycoMimetics Inc.

None

Stock Information

GlycoMimetics Inc. Company Name:

GLYC Stock Symbol:

NASDAQ Market:

GlycoMimetics Inc. Website:

Get GLYC Alerts

News, Short Squeeze, Breakout and More Instantly...

GLYC - APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia

FOSTER CITY, Calif. and HANGZHOU, China and GAITHERSBURG, Md., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and GlycoMimetics (Nasdaq: GLYC), today announc...
GLYC - New Supportive Efficacy Data for GlycoMimetics' Rivipansel in Sickle Cell Acute Vaso-Occlusive Crisis Presented at 62nd ASH Annual Meeting and Exposition

Open label study demonstrated statistically significant effects of early treatment with rivipansel on time to discharge and time to discontinuation of intravenous opioids Benefit of early intervention with E-selectin antagonist in acute VOC now reproduced in independent, conte...
GLYC - GlycoMimetics' Uproleselan in Combination With Venetoclax/HMA Shown to Break Chemoresistance, Reduce Tumor Burden and Increase Survival in AML Model

GlycoMimetics exploring investigator-sponsored follow-up human studies Oral presentation at 62nd ASH Annual Meeting and Exposition points to potential role for uproleselan as foundational therapy in acute myeloid leukemia (AML) GlycoMimetics’ (Nasdaq: GLYC) pr...